Phase II study of the farnesyl transferase inhibitor R115777 in patients with advanced non-small-cell lung cancer.

Phase II study of the farnesyl transferase inhibitor R115777 in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2003 May 01; 21(9):1760-6.

View in: PubMed

subject areas

Administration, Oral
Adult
Aged
Aged, 80 and over
Alkyl and Aryl Transferases
Anemia
Carcinoma, Non-Small-Cell Lung
Disease Progression
Farnesyltranstransferase
Female
Humans
Leukocytes, Mononuclear
Lung Neoplasms
Male
Middle Aged
Mouth Mucosa
Neutropenia
Quinolones
Survival

authors with profiles

Everett E. Vokes